75 related articles for article (PubMed ID: 26341818)
21. Hyperforin/HP-
Takada H; Yonekawa J; Matsumoto M; Furuya K; Sokabe M
Biomed Res Int; 2017; 2017():8701801. PubMed ID: 28210627
[TBL] [Abstract][Full Text] [Related]
22. The effect of novel surfactants and Solutol HS 15 on paclitaxel aqueous solubility and permeability across a Caco-2 monolayer.
Alani AW; Rao DA; Seidel R; Wang J; Jiao J; Kwon GS
J Pharm Sci; 2010 Aug; 99(8):3473-85. PubMed ID: 20198687
[TBL] [Abstract][Full Text] [Related]
23. In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam.
Bravo González RC; Huwyler J; Boess F; Walter I; Bittner B
Biopharm Drug Dispos; 2004 Jan; 25(1):37-49. PubMed ID: 14716751
[TBL] [Abstract][Full Text] [Related]
24. Biological response and cytotoxicity induced by lipid nanocapsules.
Szwed M; Torgersen ML; Kumari RV; Yadava SK; Pust S; Iversen TG; Skotland T; Giri J; Sandvig K
J Nanobiotechnology; 2020 Jan; 18(1):5. PubMed ID: 31907052
[TBL] [Abstract][Full Text] [Related]
25. Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance.
Coon JS; Knudson W; Clodfelter K; Lu B; Weinstein RS
Cancer Res; 1991 Feb; 51(3):897-902. PubMed ID: 1988130
[TBL] [Abstract][Full Text] [Related]
26. Novel radioiodinated desvenlafaxine-loaded lipid nanocapsule for brain delivery.
Ayoub VR; Abdel-Mottaleb MMA; Ibrahem IT; Motaleb MA; Geneidi AS
Arch Pharm (Weinheim); 2024 Apr; 357(4):e2300618. PubMed ID: 38161231
[TBL] [Abstract][Full Text] [Related]
27. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.
Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S
Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384
[TBL] [Abstract][Full Text] [Related]
28. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms.
Perrier T; Saulnier P; Fouchet F; Lautram N; Benoît JP
Int J Pharm; 2010 Aug; 396(1-2):204-9. PubMed ID: 20600733
[TBL] [Abstract][Full Text] [Related]
29. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.
Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E
Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585
[TBL] [Abstract][Full Text] [Related]
30. Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: evaluation of accelerated and long-term stability.
Jumaa M; Müller BW
Eur J Pharm Biopharm; 2002 Sep; 54(2):207-12. PubMed ID: 12191693
[TBL] [Abstract][Full Text] [Related]
31. Protonophore properties of hyperforin are essential for its pharmacological activity.
Sell TS; Belkacemi T; Flockerzi V; Beck A
Sci Rep; 2014 Dec; 4():7500. PubMed ID: 25511254
[TBL] [Abstract][Full Text] [Related]
32. Modulation of oxidative stress and Ca(2+) mobilization through TRPM2 channels in rat dorsal root ganglion neuron by Hypericum perforatum.
Nazıroğlu M; Çiğ B; Özgül C
Neuroscience; 2014 Mar; 263():27-35. PubMed ID: 24434769
[TBL] [Abstract][Full Text] [Related]
33. Effects of Solutol (Kolliphor) and cremophor in polyethylene glycol 400 vehicle formulations in Sprague-Dawley rats and beagle dogs.
Stokes AH; Kemp DC; Faiola B; Jordan HL; Merrill CL; Hailey JR; Brown RE; Bailey DW
Int J Toxicol; 2013; 32(3):189-97. PubMed ID: 23616145
[TBL] [Abstract][Full Text] [Related]
34. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
[TBL] [Abstract][Full Text] [Related]
35. Curcumin-loaded lipid and polymeric nanocapsules stabilized by nonionic surfactants: an in vitro and In vivo antitumor activity on B16-F10 melanoma and macrophage uptake comparative study.
Mazzarino L; Silva LF; Curta JC; Licínio MA; Costa A; Pacheco LK; Siqueira JM; Montanari J; Romero E; Assreuy J; Santos-Silva MC; Lemos-Senna E
J Biomed Nanotechnol; 2011 Jun; 7(3):406-14. PubMed ID: 21830481
[TBL] [Abstract][Full Text] [Related]
36. Raloxifene acutely reduces glutamate-induced intracellular calcium increase in cultured rat cortical neurons via inhibition of high-voltage-activated calcium current.
Huang Y; Huang YL; Lai B; Zheng P; Zhu YC; Yao T
Neuroscience; 2007 Jun; 147(2):334-41. PubMed ID: 17543470
[TBL] [Abstract][Full Text] [Related]
37. Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride.
Zhang T; Li M; Han X; Nie G; Zheng A
AAPS PharmSciTech; 2022 May; 23(5):143. PubMed ID: 35578146
[TBL] [Abstract][Full Text] [Related]
38. Enhanced Solubility and Permeability of Naringenin Across Non-Everted Sacs of Rat Small Intestine by Lipid Nanocapsules.
Vakilzadeh H; Varshosaz J; Soghrati S
Recent Pat Nanotechnol; 2021; 15(1):55-69. PubMed ID: 32735533
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of skin radical scavenging activity and stratum corneum lipids after the application of a hyperforin-rich cream.
Haag SF; Tscherch K; Arndt S; Kleemann A; Gersonde I; Lademann J; Rohn S; Meinke MC
Eur J Pharm Biopharm; 2014 Feb; 86(2):227-33. PubMed ID: 23811220
[TBL] [Abstract][Full Text] [Related]
40. Interactions of Solutol HS 15 and Cremophor EL with plasma lipoproteins.
Woodburn K; Sykes E; Kessel D
Int J Biochem Cell Biol; 1995 Jul; 27(7):693-9. PubMed ID: 7648425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
